Sweet move: A modified sugar enhances antisense oligonucleotide safety and efficacy for treating CNS disease
Researchers have found that a newly developed modified sugar increases the efficacy and safety of antisense oligonucleotides designed to treat central nervous system disease.
https://medicalxpress.com/news..../2024-05-sweet-sugar
Discover the world at Altruu, The Discovery Engine